Trudy Vanhove

Experienced biopharmaceutical executive with more than 20 years of clinical drug development and medical affairs experience in small to large pharmaceutical and biotechnology companies. I currently apply my scientific knowledge and experience to the development of molecules modulating the Wnt pathway.

Trudy served on the board of Insys Therapeutics from April 2018-February 2020 and is open to new board positions that leverage her R&D and corporate development experience.